INS and diabetes mellitus: Patch-like wearable basal-bolus insulin delivery devices such as V-Go are included in the 2019 Standards of Medical Care in Diabetes issued by the American Diabetes Association [11], and real-world evidence including the current study demonstrates the improvements in glycemic control that may be achieved with V-Go.